High-Dose Thiamine Reduces Migraine Impact in Women
- MigraineMind
- Nov 25, 2025
- 1 min read
Research Summary
A recent study published in Current Journal of Neurology explored the effects of high-dose thiamine on women with episodic migraine. This randomized, double-blind controlled trial included 40 women, divided into two groups: one receiving 990 milligrams of thiamine and the other 990 milligrams of maltodextrin daily for 12 weeks. The findings revealed that thiamine significantly reduced migraine frequency, duration, intensity, and Migraine Disability Assessment (MIDAS) scores compared to the placebo. Although both groups showed decreased serum calcitonin gene-related peptide (CGRP) levels, no notable difference was found between them. Further research is needed to confirm thiamine’s potential as an adjunctive treatment.
Study Details
👥 Research Team: Ghods M et al.
📚 Published In: Curr J Neurol
📅 Publication Date: 2024 Oct 6
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.